| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/16/1998 | WO1998030223A1 Cytokine related treatments of disease |
| 07/16/1998 | WO1998030220A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/16/1998 | WO1998030216A1 Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 07/16/1998 | WO1998030211A1 Dosage composition for nasal delivery and method of use of the same |
| 07/16/1998 | WO1998030171A1 Opiate antagonist implant and process of preparation therefor |
| 07/16/1998 | WO1998024463A3 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 07/16/1998 | CA2278158A1 Cytokine related treatments of disease |
| 07/16/1998 | CA2278137A1 Opiate antagonist implant and process of preparation therefor |
| 07/16/1998 | CA2277582A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | CA2277222A1 Treatment of lupus nephritis with anti-cd40l compounds |
| 07/16/1998 | CA2277084A1 Human chloride channel protein (hccp) |
| 07/16/1998 | CA2277034A1 Complexes and combinations of fetuin with therapeutic agents |
| 07/16/1998 | CA2272941A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/15/1998 | EP0853126A2 cDNA clone HE8CS41 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853121A2 Human DNase |
| 07/15/1998 | EP0852948A1 Use of glycosidase inhibitor for the preparation of a medicament for the prophylaxis or treatment of malaria, endotoxic shock or septic shock |
| 07/15/1998 | EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 07/15/1998 | EP0852504A1 Inhibitors of integrin receptors and their therapeutical uses |
| 07/15/1998 | EP0852497A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 07/15/1998 | EP0852494A2 Peripherally active anti-hyperalgesic opiates |
| 07/15/1998 | EP0852491A1 Use of heparinases to decrease inflammatory responses |
| 07/15/1998 | CN1187821A Rapamycin derivatives |
| 07/15/1998 | CN1187768A Combination of 5-HT uptake inhibitor with selective 5-HT1A antagonist |
| 07/14/1998 | US5780615 Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom |
| 07/14/1998 | US5780516 Material and methods for inhibiting bacterial cell wall biosynthesis |
| 07/14/1998 | US5780485 Administering adrenergic blocking agent; side effect reduction; fda orange book listed patent for silodosin |
| 07/14/1998 | US5780473 Substituted biphenyl sulfonamide endothelin antagonists |
| 07/14/1998 | US5780452 Antimalarial drug |
| 07/14/1998 | US5780446 Formulations of vesicant drugs and methods of use thereof |
| 07/14/1998 | US5780434 Composition for oral administration of peptides |
| 07/14/1998 | US5780300 Contacting human progenitor cells with agonist of notch function to inhibit differentiation of cells and exposing cells to conditions for proliferation |
| 07/14/1998 | US5780287 Photoactivated antiviral and antitumor compositions |
| 07/14/1998 | US5780049 Enhanced skin penetration system for improved topical delivery of drugs |
| 07/14/1998 | US5780028 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 07/10/1998 | CA2219960A1 Cdna clone he8cs41 that encodes a novel 7-transmembrane receptor |
| 07/09/1998 | WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029447A1 Novel human apoptosis regulator |
| 07/09/1998 | WO1998029432A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 07/09/1998 | WO1998029155A1 Method for treating peripheral affections of the facial nerve |
| 07/09/1998 | WO1998029141A1 Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes |
| 07/09/1998 | WO1998029140A1 Processes and compositions for spray drying hydrophobic drugs in organic solvent suspensions of hydrophilic excipients |
| 07/09/1998 | WO1998029123A1 Method of treating prostatic diseases using active vitamin d analogues |
| 07/09/1998 | WO1998029121A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/09/1998 | WO1998029120A1 Treatment of liposarcomas using a combination of thiazolidinediones and retinoid x receptor selective agonists |
| 07/09/1998 | WO1998029110A2 Formulation and method for treating neoplasms by inhalation |
| 07/09/1998 | WO1998029101A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/09/1998 | WO1998029098A1 Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes |
| 07/09/1998 | WO1998029096A1 Aerosolized hydrophobic drug |
| 07/09/1998 | WO1998007745A3 Compositions and methods for treating infections using analogues of indolicidin |
| 07/09/1998 | DE3590035C2 Synergistic analgesic and antiinflammatory compsn. |
| 07/09/1998 | CA2650204A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/09/1998 | CA2278340A1 Novel human apoptosis regulator |
| 07/09/1998 | CA2276745A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 07/09/1998 | CA2276450A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/08/1998 | EP0852236A1 Anti-inflammatory agent |
| 07/08/1998 | EP0852142A1 Diamines in the treatment of arrhythmia |
| 07/08/1998 | EP0851768A2 Interactive molecular conjugates |
| 07/08/1998 | EP0851756A1 5-ht 3? receptor antagonists for dyskinesia |
| 07/08/1998 | EP0851753A1 Aerosol compositions |
| 07/08/1998 | EP0777478A4 Inhibitors of rotamase enzyme activity |
| 07/08/1998 | EP0730589B1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 07/08/1998 | EP0667959A4 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE -g(b)-AMYLOID PEPTIDE. |
| 07/08/1998 | CN1187188A Small molecule inhibitors of rotamase enzyme activity |
| 07/08/1998 | CN1187137A Novel targeted compositions for diagnostic and therapeutic use |
| 07/08/1998 | CN1187123A Treatment for ocular inflammation |
| 07/08/1998 | CN1186806A 整联蛋白受体拮抗剂 Integrin receptor antagonists |
| 07/08/1998 | CA2210677A1 Use of glycosidase inhibitors |
| 07/07/1998 | US5776968 Therapeutic uses of melanin |
| 07/07/1998 | US5776783 Method of monitoring therapeutic agent consumption |
| 07/07/1998 | US5776750 Amino acid sequences and polypeptides for hybridizing and genes |
| 07/07/1998 | US5776743 Method of sensitizing tumor cells with adenovirus E1A |
| 07/07/1998 | US5776729 Human G-protein receptor HGBER32 |
| 07/07/1998 | US5776498 Nutritional supplement, therapeutic and prophylactic agent |
| 07/07/1998 | US5776489 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 07/07/1998 | US5776485 Nonionic polyacrylamide with high molecular weight for drug delivery |
| 07/07/1998 | US5776464 Administering heptocyte growth factor |
| 07/07/1998 | US5776456 Administering a polypeptide |
| 07/07/1998 | US5776095 Pretargeting noncanerous cells or tissues with a cytoprotective agents before therapy with radiation or anticarcinogenic agents |
| 07/07/1998 | US5776094 Method and kit for imaging and treating organs and tissues |
| 07/07/1998 | US5776093 Method for imaging and treating organs and tissues |
| 07/07/1998 | CA2163446C Pyrazolopyrimidinones for the treatment of impotence |
| 07/07/1998 | CA2111932C Quick-drying gel-type disinfectant for hands and fingers |
| 07/02/1998 | WO1998028621A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | WO1998028442A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | WO1998028330A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028264A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 07/02/1998 | WO1998027998A1 Remedies for cerebral ischemic diseases |
| 07/02/1998 | WO1998027995A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | WO1998027988A1 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 07/02/1998 | WO1998027976A1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists |
| 07/02/1998 | WO1998027973A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 07/02/1998 | WO1998027971A1 Pharmaceutical composition for treating fecal incontinence and anal itch |
| 07/02/1998 | WO1998027959A2 New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 07/02/1998 | WO1998027932A2 Cerebellum and embryo specific protein |
| 07/02/1998 | WO1998027817A1 Endoparasiticidal and ectoparasiticidal agents |
| 07/02/1998 | WO1998027813A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276149A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2275681A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |